Richard Silver, MD
Urology · Kissimmee, FLNPI 1346573912
Payments from drug & device makers
Across 69 payments — averaging $80.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Coloplast$307
- Astellas Pharma US Inc$215
- Procept Biorobotics Corporation$166
- Boston Scientific$102
- Bayer$86
- plus $547 from 17 others
What the payments were for
- Consulting fees$3,30059%
- Travel & lodging$5039%
- Food & beverage$1,68930%
- Education$751%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $4,143 |
| Coloplast | 7 | $307 |
| Astellas Pharma US Inc | 9 | $215 |
| Procept Biorobotics Corporation | 3 | $166 |
| Boston Scientific | 3 | $102 |
| Bayer | 5 | $86 |
| Dendreon Pharmaceuticals LLC | 3 | $80 |
| Antares Pharma, Inc. | 3 | $59 |
| Tolmar Pharmaceuticals, Inc. | 4 | $59 |
| Johnson & Johnson | 3 | $55 |
| Pfizer | 4 | $51 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $45 |
| Blue Earth Diagnostics | 1 | $37 |
| Axonics, Inc. | 1 | $25 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Urovant Sciences Inc | 1 | $17 |
| Mission Pharmacal Company | 1 | $16 |
| 180 Medical, Inc. | 1 | $16 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $13 |
| Metuchen Pharmaceuticals | 1 | $12 |
| Amgen | 1 | $11 |
| Travere Therapeutics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$109
How this compares
$5,567 in reported general payments places this provider in the 55th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride ErOxybutynin Chloride | 107 | $4,765 |
| Tamsulosin Hcl | 174 | $1,655 |
| Finasteride | 115 | $1,270 |
| Methenamine Hippurate | 12 | $767 |
| Bicalutamide | 11 | $429 |
| Cephalexin | 36 | $194 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $134 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $115 |
| Indapamide | 12 | $112 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $89 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $74 |
| Ciprofloxacin Hcl | 12 | $59 |
| Levofloxacin | 12 | $30 |
Paid to pharmacies, not to this prescriber.
Other urology in Kissimmee
- Steven KesterPompano Beach$5.7M
- Harvey SamowitzHallandale Beach$3.6M
- Paul PeritoCoral Gables$3.6M
- Graham GreeneLakeland$2.5M
- Scott SellingerTallahassee$2.3M
- Fernando BiancoHialeah$2.2M
- Osvaldo PadronTampa$1.3M
- Mark Anthony GonzalgoMiami$1.1M
- Paul CrispenGainesville$1.1M
- Craig HermanPompano Beach$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.